Hubertus von Baumbach

From WikiProjectMed
Jump to navigation Jump to search
Hubertus von Baumbach
Born1966 or 1967 (age 56–57)[1]
NationalityGerman
EducationMassachusetts Institute of Technology
OccupationBusinessman
TitleChairman and CEO, Boehringer Ingelheim

Hubertus von Baumbach (born 1967) is a German businessman who is the chairman and CEO of Boehringer Ingelheim, Germany's second largest pharmaceutical company.[2]

Early life and education

The son of Erich von Baumbach and Ulrike Boehringer, Hubertus von Baumbach is also a great-grandson of the company's founder Albert Boehringer.[1] He has a law degree and an MBA from the Massachusetts Institute of Technology.[3][2]

Career

Baumbach joined Boehringer Ingelheim in 2001.[3]

In November 2015, it was announced that Baumbach, who had been CFO, was appointed as chief executive, succeeding Andreas Barner in June 2016.[1][2] At the time, this made him the first member of the family at the helm in 25 years.[4] Within his first six months, he launched the biggest acquisition in the company's history (an asset swap deal with French rival Sanofi), followed by a reorganization to give the group a more decentralized divisional structure.[5]

In his capacity at Boehringer Ingelheim, Baumbach was part of Chancellor Angela Merkel’s delegation on three state visits to China.[6]

Other activities

Corporate boards

Non-profit organizations

  • Federation of German Industries (BDI), Member of the Presidium (2018-2019)[9]
  • German Chemical Industry Association (VCI), Member of the Executive Committee[10]
  • Baden-Badener Unternehmer-Gespräche (BBUG), Member of the Board of Trustees[11]
  • Cultural Foundation of the Federal States, Member of the Board of Trustees[12]
  • Städel Museum, Member of the Administration[13] and the Board of Trustees[14]
  • Stiftung Tausendgut, Member of the Board of Trustees[15]

References

  1. ^ a b c Editorial, Reuters (6 November 2015). "Boehringer appoints first CEO from founding family in 25 years". reuters.com. Retrieved 7 November 2018. {{cite news}}: |first= has generic name (help)
  2. ^ a b c "Drug firm Boehringer Ingelheim on a high". handelsblatt.com. 27 April 2018. Retrieved 7 November 2018.
  3. ^ a b "Board of Managing Directors - boehringer-ingelheim.com". boehringer-ingelheim.com. Retrieved 7 November 2018.
  4. ^ Patricia Weiss and Maria Sheahan (November 6, 2015), Boehringer appoints first CEO from founding family in 25 years Reuters .
  5. ^ Siegfried Hofmann (April 27, 2018), Drug firm Boehringer Ingelheim on a high Handelsblatt .
  6. ^ Christian Schlesiger (September 8, 2017), Siemens-Chef Kaeser am häufigsten bei Delegationsreisen dabei Wirtschaftswoche.
  7. ^ Members of the Advisory Board, 2010 Deutsche Bank.
  8. ^ 2015 Annual Report Landesbank Baden-Württemberg (LBBW).
  9. ^ Presidium Federation of German Industries (BDI).
  10. ^ "Vorstand & Präsidium - Verband der Chemischen Industrie e.V. (VCI)". www.vci.de (in German). Retrieved 2017-06-01.
  11. ^ Board of Trustees Baden-Badener Unternehmer-Gespräche (BBUG).
  12. ^ Board of Trustees Cultural Foundation of the Federal States.
  13. ^ Administration Städel Museum.
  14. ^ Board of Trustees Städel Museum.
  15. ^ Board of Trustees Stiftung Tausendgut.


Stub icon

This German business-related biographical article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://mdwiki.org/wiki/Hubertus_von_Baumbach"